Friday, May 10, 2013 6:20:06 PM
If the volume picks up I smell something good. It would be nice to be right on one these pennies. Any positive news sends this issue much higher IMO.
I do suggest you take a look (as Ante initially suggested) at BPTH. I have done substantial research and if their antisense drug works it could be game changer. I actually had my own independent expert look at this company's explanation of their technology. The majority shareholder of the company is the premier cancer in the world, MD Anderson Cancer Center at U of Texas in Houston.
They are near the end of Phase I testing and there is no sign toxicity. If Phase II shows anti-leukemic properties (as in their animal studies and in Phase I as alluded to by the company) things will happen quickly for BPTH do to the paucity of any side effects.
In meantime, let us hope CGNH gets their act together.
Recent CGNH News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/26/2024 04:25:43 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM